A method and composition to extract of several processed herbal medicinal plants and an herbal tea composition for ingestion which contains the extract. The functional herbal extraction method and composition is used to relieve the symptoms of cough and throat discomfort. This composition creates a synergy between different ingredients that works to suppress cough, yellow or green phlegm, sore throat and specifically to treat hot cough. The composition can include Shi Gao, Hai Fu Shi, Chuan Bei Mu, Tian Zhu Huang, Ban Xia, Yu Xing Cao, Tian Kui Zi, Gan Cao, Tian Nan Xing, Chai Hu, Huang Qin, Zhi Shi, Bai Shao, Chen Pi, Kuan Dong Hua, Zi Wan, Sheng Jiang. The effectiveness of the herbal tea is at least partially dependent on the desired means of preparation and administering the composition.

The invention relates to a method for production of a preparation from a vegetable material, said preparation being enriched in a polysaccharide with a backbone comprising rhamnogalacturonan-I cores, said method comprising the steps: mixing the vegetable material with a polar alcoholic solvent; and separating a solid residue obtained in step a) from the solvent; and mixing the solid residue obtained in step b) with a buffered aqueous solution having a pH between 7 and 8. Also provided is a preparation containing rhamnogalacturonan-I pectins that can be obtained by this method and the use of such a preparation to modulate immune response.

The invention relates to a method for production of a preparation from a vegetable material, said preparation being enriched in a polysaccharide with a backbone comprising rhamnogalacturonan-I cores, said method comprising the steps: mixing the vegetable material with a polar alcoholic solvent; and separating a solid residue obtained in step a) from the solvent; and mixing the solid residue obtained in step b) with a buffered aqueous solution having a pH between 7 and 8. Also provided is a preparation containing rhamnogalacturonan-I pectins that can be obtained by this method and the use of such a preparation to modulate immune response.

The invention relates to a method for production of a preparation from a vegetable material, said preparation being enriched in a polysaccharide with a backbone comprising rhamnogalacturonan-I cores, said method comprising the steps: mixing the vegetable material with a polar alcoholic solvent; and separating a solid residue obtained in step a) from the solvent; and mixing the solid residue obtained in step b) with a buffered aqueous solution having a pH between 7 and 8. Also provided is a preparation containing rhamnogalacturonan-I pectins that can be obtained by this method and the use of such a preparation to modulate immune response.

The present invention discloses a novel application of ginsenoside Rd in preparation of a drug for relieving or/and treating inflammations and health food/medicinal and edible food/functional food/dietary supplement. Tests prove that ginsenoside Rd has a remarkable curative effect on inflammations, takes effect quickly, has a better effect than Dexamethasone, is suitable for both acute inflammations such as influenza virus pneumonia, novel coronavirus pneumonia and acute lung injury inflammations, and chronic inflammations such as chronic obstructive pneumonia and chronic asthmatic airway inflammations, and is regarded as a new drug source for treating acute and chronic inflammations and complications thereof.

The present invention discloses a novel application of ginsenoside Rd in preparation of a drug for relieving or/and treating inflammations and health food/medicinal and edible food/functional food/dietary supplement. Tests prove that ginsenoside Rd has a remarkable curative effect on inflammations, takes effect quickly, has a better effect than Dexamethasone, is suitable for both acute inflammations such as influenza virus pneumonia, novel coronavirus pneumonia and acute lung injury inflammations, and chronic inflammations such as chronic obstructive pneumonia and chronic asthmatic airway inflammations, and is regarded as a new drug source for treating acute and chronic inflammations and complications thereof.

The disclosure relates to a traditional Chinese medicine composition, comprising active ingredients derived from Cornu caprae or Cornu saigae tataricae, Radix scutellariae, Bulbus fritillariae ussuriensis, Radix glycyrrhizae, Radix et rhizoma rhei, Gypsum fibrosum, Calculus bovis artifactus and Lapis Chloriti, the said active ingredients comprise in parts by weight: at least 1600 parts of amino acids; at least 120 parts of gallic acid; at least 130 parts of liquiritin; at least 20 parts of liquiritigenin; at least 400 parts of baicalin; at least 40 parts of oroxyloside; at least 120 parts of wogonoside; at least 280 parts of glycyrrhizic acid; at least 12 parts of chrysin-7-O--D-glucoronic acid; at least 50 parts of aloe-emodin-8-O--D-glucopyranoside; at least 30 parts of chrysophanol-1-O--D-glucopyranoside; at least 45 parts of chrysophanol-8-O--D-glucopyranoside; at least 260 parts of hyodeoxycholic acid; at least 150 parts of cholic acid. The traditional Chinese medicine composition in the present invention possess antipyretic, anti-inflammatory and antitussive effects.

The disclosure relates to a traditional Chinese medicine composition, comprising active ingredients derived from Cornu caprae or Cornu saigae tataricae, Radix scutellariae, Bulbus fritillariae ussuriensis, Radix glycyrrhizae, Radix et rhizoma rhei, Gypsum fibrosum, Calculus bovis artifactus and Lapis Chloriti, the said active ingredients comprise in parts by weight: at least 1600 parts of amino acids; at least 120 parts of gallic acid; at least 130 parts of liquiritin; at least 20 parts of liquiritigenin; at least 400 parts of baicalin; at least 40 parts of oroxyloside; at least 120 parts of wogonoside; at least 280 parts of glycyrrhizic acid; at least 12 parts of chrysin-7-O--D-glucoronic acid; at least 50 parts of aloe-emodin-8-O--D-glucopyranoside; at least 30 parts of chrysophanol-1-O--D-glucopyranoside; at least 45 parts of chrysophanol-8-O--D-glucopyranoside; at least 260 parts of hyodeoxycholic acid; at least 150 parts of cholic acid. The traditional Chinese medicine composition in the present invention possess antipyretic, anti-inflammatory and antitussive effects.

The present disclosure provides a traditional Chinese medicine composition for treating gastroesophageal reflux disease (GERD), including the following raw materials in parts by weight: 10 parts to 25 parts of Fructus trichosanthis, 10 parts to 30 parts of Radix scrophulariae, 10 parts to 20 parts of Os sepiae, 3 parts to 6 parts of Fructus evodiae, 6 parts to 12 parts of Ramulus cinnamomi, 5 parts to 15 parts of Rhizoma coptidis, 10 parts to 20 parts of Radix paeoniae alba, 10 parts to 20 parts of Radix ophiopogonis, 10 parts to 20 parts of red ochre, 10 parts to 20 parts of calcined Ossa draconis, 10 parts to 20 parts of calcined Concha ostreae, 10 parts to 30 parts of Radix rehmanniae, 10 parts to 20 parts of Bulbus fritillariae thunbergii, 10 parts to 20 parts of Radix asparagi, 10 parts to 30 parts of Radix Astragali.

The present disclosure provides a traditional Chinese medicine composition for treating gastroesophageal reflux disease (GERD), including the following raw materials in parts by weight: 10 parts to 25 parts of Fructus trichosanthis, 10 parts to 30 parts of Radix scrophulariae, 10 parts to 20 parts of Os sepiae, 3 parts to 6 parts of Fructus evodiae, 6 parts to 12 parts of Ramulus cinnamomi, 5 parts to 15 parts of Rhizoma coptidis, 10 parts to 20 parts of Radix paeoniae alba, 10 parts to 20 parts of Radix ophiopogonis, 10 parts to 20 parts of red ochre, 10 parts to 20 parts of calcined Ossa draconis, 10 parts to 20 parts of calcined Concha ostreae, 10 parts to 30 parts of Radix rehmanniae, 10 parts to 20 parts of Bulbus fritillariae thunbergii, 10 parts to 20 parts of Radix asparagi, 10 parts to 30 parts of Radix Astragali.